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25, 72076 Tuebingen, GermanyAbstract—The gate control theory proposed that the noci-
ceptive sensory information transmitted to the brain relies
on an interplay between the inputs from nociceptive and
non-nociceptive primary aﬀerent ﬁbers. Both inputs are
normally under strong inhibitory control in the spinal cord.
Under healthy conditions, presynaptic inhibition activated
by non-nociceptive ﬁbers modulates the aﬀerent input from
nociceptive ﬁbers onto spinal cord neurons, while postsyn-
aptic inhibition controls the excitability of dorsal horn neu-
rons, and silences the non-nociceptive information ﬂow to
nociceptive-speciﬁc (NS) projection neurons. However,
under pathological conditions, this spinal inhibition may
be altered and lead to chronic pain. This review summarizes
our knowledge of presynaptic inhibition in pain control, with
particular focus on how its alteration after nerve or tissue
injury contributes to neuropathic or inﬂammatory pain
syndromes, respectively.
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SPINAL INHIBITION
Chronic pain may not be one of the leading causes of
death, such as cardiovascular disease, cancer, and
diabetes (WHO, 2008), but it aﬀects more people than
these three diseases together, i.e. 116 million adults in
the U.S. and 20% of the adult European population
(Breivik et al., 2006; Institute of Medicine, 2011). It highly
impairs patients’ mood, quality of life, activities of daily life
and performance at work. The annual cost of chronic pain
is $560–635 billion in the U.S, higher than the costs of
cardiovascular diseases, cancers, and diabetes com-
bined (Institute of Medicine, 2011). Unfortunately the
treatments currently covered by such an enormous
expense do not fully alleviate patients’ suﬀering and often
elicit numerous side eﬀects. A focus on understanding
and targeting the underlying molecular and cellular mech-
anisms of chronic pain is urgently required. In the last
decade, remarkable eﬀorts have been made and impor-
tant conceptual advances have been achieved, among
which, loss of inhibition in the dorsal horn of the spinal
cord is widely accepted as a key mechanism contributing
to the initiation and maintenance of chronic pain (Enna
and McCarson, 2006; Zeilhofer et al., 2012; Bonin and
De Koninck, 2013).Spinal nociceptive processing
Spinal dorsal horn is the ﬁrst relay in the central nervous
system (CNS) where nociceptive input from primary
sensory aﬀerents is integrated and further transmitted to
higher brain centers, where conscious pain perception
arises. Determined by their axon size and sensory
modalities, the primary aﬀerents terminate in diﬀerent
laminae of the dorsal horn (Todd, 2010). Generally speak-
ing, the superﬁcial dorsal horn (laminae I–IIo) is mostly
innervated by nociceptive ﬁbers, whereas ﬁbers frommons.org/licenses/by-nc-nd/3.0/).
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deep dorsal horn (laminae IIi–V). Projection neurons are
mostly located in laminar I and scattered throughout lam-
inae III–VI. Surprisingly, despite their importance in trans-
mitting information to the brain, projection neurons only
make up a small proportion of the neurons in the spinal
cord, e.g. nociceptive-speciﬁc (NS) projection neurons
compose 5% of lamina I neurons (Spike et al., 2003).
The vast majority of neurons in laminae I–III are interneu-
rons. In rats, GABA-immunoreactivity is present in 25%,
30% and 40% of neurons in laminae I, II and III, respec-
tively. Most of the glycine-immunoreactive cell bodies in
laminae I–III are also GABA-immunoreactive with the
exception of some neurons in lamina III (Polgar et al.,
2003). This abundance of inhibitory interneurons in the
spinal cord strongly suggests an important functional role
of inhibition in pain information processing. About half
century ago, Melzack and Wall ﬁrst proposed that these
inhibitory interneurons function as a gate in spinal dorsal
horn. The balance between the inputs from nociceptive
and non-nociceptive primary ﬁbers which is controlled
by the complex spinal inhibitory interneuron circuits deter-
mines the status of this gate, i.e. whether and how strong
the nociceptive information will be transmitted, via NS
projection neurons, to higher brain centers. This inhibitory
gate is also responsible for keeping nociceptive and non-
nociceptive modalities apart under normal healthy condi-
tion (Fig. 1). In line with this, the gate control theory further
predicts that under pathological conditions, a disrupt of
the spinal inhibitory circuit eﬃcacy may contribute to
chronic pain development (Melzack and Wall, 1965).
Since then, a large body of evidence from
pharmacological and behavior studies have conﬁrmed
the importance of spinal inhibition in controlling pain
information processing. Enhancing spinal GABAergic
inhibition by intrathecal application of GABA or a
positive allosteric modulator (PAM), such as diazepam
(DZP), exhibits a clear antinociceptive eﬀect and
reverses chronic pain induced by nerve injury (Roberts
et al., 1986; Sawynok, 1987; Malcangio and Bowery,
1996; Dickenson et al., 1997; Zeilhofer et al., 2012). On
the contrary, blockade of GABA-mediated inhibition in
the spinal cord produces an increased nociceptive reac-
tion to noxious stimuli (hyperalgesia) and painful sensa-
tions to innocuous stimuli (tactile allodynia) (Roberts
et al., 1986; Sivilotti and Woolf, 1994; Sorkin et al.,
1998; Loomis et al., 2001; Zhang et al., 2001; Malan
et al., 2002). Hyperalgesia and tactile allodynia are the
two major symptoms of chronic pain. Thus diminishing
inhibitory pain control in the spinal dorsal horn could rep-
licate the main characteristics of chronic pain states as
predicted by the gate control theory. Indeed, a decrease
in inhibition, or ‘‘disinhibition’’, has been shown as an
important substrate of many chronic pain models
(Woolf, 2000; Baba et al., 2003; Cervero et al., 2003;
Coull et al., 2003; Enna and McCarson, 2006; Gwak
and Hulsebosch, 2011; Puri et al., 2012; Zeilhofer et al.,
2012; Bardoni et al., 2013; Bonin and De Koninck,
2013; Lu et al., 2013). This disinhibition results in a gen-
eral increase in the excitability of networks of neurons,
and can allow activation of sensory pathways that arenormally silenced by inhibition, such as the excitatory
input from non-nociceptive ﬁbers to NS projection
neurons in lamina I.
Spinal GABAergic inhibition
The GABAA receptor can modulate spinal nociceptive
processing via two mechanisms: GABAA receptors
located in primary aﬀerent terminals of nociceptors
cause reduction in transmitter release thus modulating
the aﬀerent input from DRG neurons into NS projection
neurons (presynaptic inhibition), while postsynaptic
GABAA receptors in spinal cord neurons directly reduce
their excitability and therefore control the output
(postsynaptic inhibition). Both pre- and postsynaptic
inhibition are controlled by local inhibitory interneurons
and inhibitory descending ﬁbers (Zeilhofer et al., 2012).
While there is growing evidence indicating that spinal inhi-
bition contributes to physiological and pathological pain
sensation (Enna and McCarson, 2006; Knabl et al.,
2008; Munro et al., 2011; Zeilhofer et al., 2012; Bardoni
et al., 2013; Bonin and De Koninck, 2013; Braz et al.,
2014), the precise contribution of diﬀerent modes of inhi-
bition (pre vs. post) in various pain modalities is not
known. This is mainly due to the diﬃculties to selectively
manipulate pre- or postsynaptic inhibition. The postsynap-
tic inhibition and its role in chronic pain have been inten-
sively reviewed elsewhere (Dickenson et al., 1997;
Cattaert et al., 2001; Zeilhofer et al., 2012; Bonin and
De Koninck, 2013; Prescott et al., 2014). In this review,
we will focus on presynaptic inhibition and its alteration
after tissue or nerve injury.
PRESYNAPTIC INHIBITION
GABAA receptors expressed on primary sensory
neurons
GABAA receptors are ligand-gated heteropentameric
chloride ion channels encoded by a family of at least 19
subunits (a1–6, b1–3, c1–3, d, e, h, p, q1–3). The most
common subtype of GABAA receptors contains two a,
two b, and one c subunit. Several lines of evidence
indicate that GABAA receptors are present on primary
sensory neurons to mediate presynaptic inhibition
(Table 1). In situ hybridization studies localized the
mRNA for a2, b3, and c2 subunits in both large- and
small-diameter adult rat DRG neurons (Persohn et al.,
1991; Ma et al., 1993). The distribution of GABAA recep-
tors has also been assessed in cultured embryonic and
adult human DRGs using reverse-transcript PCR (RT-
PCR) which conﬁrmed the expression of a2 and b3
mRNA in both embryonic and adult cultures (Maddox
et al., 2004). These ﬁndings provide a molecular basis
for the presynaptic inhibition. However, the direct evi-
dence for the expression of diﬀerent isoforms of GABAA
receptors on primary aﬀerent terminals in the spinal cord
was not present until a recent study from Zeilhofer’s lab-
oratory (Paul et al., 2012). By utilizing immunohistochem-
istry with subunit-speciﬁc antibodies combined with
markers of primary aﬀerents the authors revealed a selec-
tive distribution of GABAA receptor subunits a1–3 and a5
Fig. 1. Balance between primary aﬀerent-derived excitatory and inhibitory drives to the spinal cord dorsal horn. Stimulation of non-nociceptive Ab
ﬁbers induces activation of inhibitory interneurons 1 and 2. GABA release from neuron 1 which is possibly GAD65 positive as discussed in review
causes the activation of GABAA receptors expressed on C and Ad nociceptive aﬀerent terminals, leads to the generation of PAD and therefore
inhibition of glutamate release onto nociceptive-speciﬁc (NS) projection neuron (presynaptic inhibition). Neuron 2 directly establishes synaptic
connections to NS projection neurons and reduces its excitability thus controlling the output (postsynaptic inhibition). There also exists a normally
silent excitatory linkage from non-nociceptive Ab ﬁbers to PKCc+ cell and further to excitatory interneuron. This connection is inhibited by
glycinergic interneuron 3 which receives input from low-threshold Ab ﬁbers as well. In the setting of nerve injury, the postsynaptic inhibition derived
from neurons 2 and 3 are disrupted through various mechanisms. Therefore the innocuous inputs gain access to the nociceptive pathway and
activate NS projection neuron, leading to tactile allodynia. In parallel, [Cl]i in primary aﬀerents is upregulated accompanied by a reduction of GABAA
receptor conductance, leading to a loss of presynaptic inhibition, hence, heat hyperalgesia. In the setting of tissue injury, [Cl]i in primary aﬀerents is
upregulated as well as GABAA receptor conductance. Inputs from non-nociceptive Ab ﬁbers could then, via GABAergic interneurons 1, evoke action
potentials in nociceptive aﬀerents, from where excitation could spread both anterogradely and retrogradely (as DRR), to induce touch-evoked pain
and neurogenic inﬂammation.
Table 1. Summary of the major GABAA receptor subtypes expressed in DRG
Subunit Type of tissue Method References
a1 Adult mouse IHC Paul et al. (2012)
Adult rat ISH Persohn et al. (1991)
a2 Adult mouse IHC Paul et al. (2012)
Adult rat ISH Persohn et al. (1991)
Embryonic, postnatal and adult rat ISH, RT-PCR Ma et al. (1993)
Embryonic and adult human DRG neurons in culture RT-PCR Maddox et al. (2004)
Adult rat ISH Fukuoka et al. (1998)
a3 Adult mouse IHC Paul et al. (2012)
Embryonic, postnatal and adult rat ISH, RT-PCR Ma et al. (1993)
a5 Adult mouse IHC Paul et al. (2012)
Embryonic, postnatal and adult rat ISH, RT-PCR Ma et al. (1993)
b2 Adult rat ISH Persohn et al. (1991)
Embryonic and adult human DRG culture RT-PCR Maddox et al. (2004)
Embryonic, postnatal and adult rat ISH, RT-PCR Ma et al. (1993)
b3 Embryonic, postnatal and adult rat ISH, RT-PCR Ma et al. (1993)
Embryonic and adult human DRG culture RT-PCR Maddox et al. (2004)
c2 Adult rat ISH Persohn et al. (1991)
Embryonic, postnatal and adult rat ISH, RT-PCR Ma et al. (1993)
Abbreviations: DRG, dorsal root ganglion; IHC, immunohistochemistry; ISH, in situ hybridization; RT-PCR, reverse transcription polymerase chain reaction.
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and non-nociceptive aﬀerents. Speciﬁcally, c ﬁbers pre-
dominantly express either a2 or a3, while myelinated
ﬁbers contain equally all four subunits (Paul et al., 2012).Function of presynaptic inhibition
Evidence supporting an analgesic action of spinal GABAA
receptor activation comes from local injection of muscimol
or GABA at the spinal cord level which reduces
nociceptive responses (Roberts et al., 1986; Dickenson
et al., 1997; Wei et al., 2010). Moreover, the phenotype
of pain behavior in GABAA receptor b3 subunit knockout
(GABRB3/) mice displays an increased sensitivity to
heat and mechanical stimuli (Ugarte et al., 2000). How-
ever, none of these studies made a clear distinction
between pre- and postsynaptic inhibition. First eﬀort has
been nicely made again by Zeilhofer’s laboratory. They
have applied a genetic approach to selectively knockout
presynaptic GABAA receptor a2 subunit on spinal noci-
ceptor terminals (sns-a2/ mice) in order to address
the contribution of presynaptic inhibition to spinal pain
control (Witschi et al., 2011). Ablation of a2-GABAA
receptors almost completely abolished the potentiating
eﬀect of the positive allosteric GABAA receptor modulator
DZP on primary aﬀerent depolarization (PAD) and its
spinal antihyperalgesic action against inﬂammatory
hyperalgesia was also reduced. It is known that GABAA
receptors containing a1, a2, a3, or a5 subunits associ-
ated with the c2 subunit are sensitive to DZP (Zeilhofer
et al., 2012). Thus this study provided evidence that the
antihyperalgesic action of spinally applied DZP occurs lar-
gely through facilitating presynaptic inhibition (Witschi
et al., 2011). Surprisingly, GABAergic membrane currents
recorded from nociceptive DRG neurons are the same
between WT and sns-a2/ mice. Furthermore, sns-
a2/ mice exhibited normal response thresholds to ther-
mal and mechanical stimulation, and developed normal
inﬂammatory and neuropathic pain. This might be due to
the upregulation of benzodiazepine-insensitive GABAA
receptor subunits which made this transgenic mouse
model not suitable for directly demonstrating the function
of presynaptic inhibition in spinal pain control.
As we have noted above, b3 subunit has been shown
by diﬀerent studies as the most dominant b subunit
expressed in DRG neurons. So we sought to generate a
new mouse line in which GABAA receptor b3 subunit is
selectively knocked out in primary nociceptors (sns-
b3/ mice). The amplitude of GABAA receptor current
is signiﬁcantly reduced in sns- b3/ mice compared to
wild-type mice demonstrating a functional loss of
presynaptic GABAA receptors. Intriguingly, sns- b3
/
mice exhibited a hypersensitive phenotype to both
noxious heat and mechanical stimulation compared to
wild-type mice. In contrast, acute sensitivity to cold
stimulus is not aﬀected in sns- b3/ mice (Chen et al.,
2014). To our knowledge, this is the ﬁrst in vivo evidence
showing the presynaptic GABAA receptor is required for
controlling both heat and mechanical pain signal process-
ing under healthy condition.Mechanisms of presynaptic inhibition
Activation ofGABAA receptors opens ligand-gated chloride
ion channels. In the nervous system, the strength and
polarity of GABA-mediated neurotransmission largely
depend on the intracellular chloride concentration [Cl]i.
And the [Cl]i is determined, in part, by the activities of
cation-chloride cotransporters (CCCs) including the
inwardly directed Na–K–2Cl cotransporter (NKCC1) and
various outwardly directed K–Cl cotransporters, such as
KCC2 and KCC3 (Kahle et al., 2008). During CNSmatura-
tion,GABAergic signaling switches fromexcitatory to inhib-
itory by controlling the KCC2 activity relative to NKCC1
activity (Kahle et al., 2008; Benarroch, 2013). Unlike neu-
rons in the adult central nervous system, under physiolog-
ical conditions, NKCC1 is still expressed at high levels in
DRG neurons while KCC2 and KCC3 are expressed at
low levels or even absent (Alvarez-Leefmans et al., 2001;
Kanaka et al., 2001; Price et al., 2006; Mao et al., 2012).
As a consequence, DRG neurons maintain a high level of
[Cl]i which results in a positive equilibrium potential for
chlorideECl relative toneuron’s restingmembranepotential
(Vm), so the opening of chloride channels on primary aﬀer-
ent terminals by GABA causes net chloride eﬄux and con-
sequently depolarizes the neurons. However this PAD
inhibits rather than facilitates transmitter release from the
primary aﬀerent terminal. Diﬀerentmechanisms have been
proposed to explain how GABA-mediated PAD produces
presynaptic inhibition: (1) PADmay lead to the inactivation
of voltage-gated sodium (NaV) channels on primary aﬀer-
ent axons and/or terminals and thus interrupt orthodromic
propagation of action potentials from periphery; (2) PAD
may attenuate the amplitude of propagated action poten-
tials through an increase in membrane conductance pro-
duced by opening chloride channels (shunting) thus
ultimately reducing transmitter release to the second-order
neurons in the spinal dorsal horn; (3) Alternatively, PAD
may inactivate the voltage-gated calcium channels on ter-
minals thus reducing presynaptic calcium inﬂux and trans-
mitter release (Rudomin and Schmidt, 1999; Price et al.,
2009;Zeilhofer et al., 2012).However, the relative contribu-
tion of these three mechanisms to presynaptic inhibition in
primary nociceptors is still under debate (Cattaert and El
Manira, 1999; Willis, 1999, 2006; Cattaert et al., 2001;
Panek et al., 2002; French et al., 2006). The inactivation
of the NaV channels by depolarization depends on the bio-
physical properties of the channels expressed in primary
sensory neurons. Most NaV channels expressed in large
diameter (non-nociceptive) sensory ﬁbers are subject to
steady-state inactivation over a voltage-range spanning
typical resting membrane potential (i.e., 80 to 50 mV).
In contrast, high density of tetrodotoxin-resistant (TTX-R)
NaV channels which are resistant to steady-state inactiva-
tion are detected in central terminals of nociceptive ﬁbers
(Jeftinija, 1994; Gold et al., 1996; Zhu et al., 2012). This
raises the question whether GABA-induced depolarization
could eﬀectively inactivate the major TTX-R NaV channels
expressed in nociceptive primary aﬀerents andblockaction
potential propagation. The depolarization eﬀect has also
been studied via investigating the functional role of NKCC1
in nociceptive processing. DRG neurons isolated from
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implicating a reduced depolarization by GABA in neurons
lacking NKCC1. Interestingly, NKCC1mutant mice display
signiﬁcant increased latencies to withdrawal from noxious
heat in the hot plate test and tail ﬂick test, paradoxically sug-
gestinga further inhibitory eﬀect by reducedPADamplitude
(Sunget al., 2000; Laird et al., 2004).However,NKCC1-KO
mice showmajor deﬁcits inmotor coordination (Sung et al.,
2000), therefore, more selective manipulation of NKCC1 is
needed to gain a better understanding of the role of NKCC1
in presynaptic inhibition and thermal nociception.
Under physiological conditions, aﬀerent inputs from
non-nociceptive neurons, via interconnected spinal
inhibitory interneurons, control the gate of nociceptive
information ﬂow by pre- and postsynaptic inhibition, thus
touch could close the gate of pain, or reduce pain
(Fig. 1). In addition, there exists a closed gate from low-
threshold Ab ﬁbers to NS projection neurons in lamina I.
Both inhibitory and excitatory Ab ﬁber inputs converge
onto PKCY
+ neurons in the superﬁcial dorsal horn to
form a feed-forward inhibitory circuit which prevents Ab
input from activating the nociceptive pathway (Fig. 1)
(Malan et al., 2002; Miraucourt et al., 2007; Bardoni
et al., 2013; Lu et al., 2013). Under chronic pain condi-
tions, the status of these gates may be changed. There
is ample evidence indicating that a reduction of spinal
inhibition or in extreme case even a switch to excitation
is a powerful contributing factor to neuropathic and inﬂam-
matory pain. Considerable studies which investigated the
eﬀect of modulating GABA transmission on chronic pain
have been reported, however, yielding conﬂicting results.
Several reports have demonstrated GABA or GABAA
receptor PAMs mediate robust analgesia, whereas others
have found GABA or PAM exacerbate pain syndromes
(Bianchi et al., 1993; Rode et al., 2005; Knabl et al.,
2008; Munro et al., 2009, 2011; Mirza and Munro,
2010). Since most inconsistency come from inﬂammatory
pain studies, a possible explanation is that diﬀerent injury
modes (e.g. nerve injury vs. tissue injury) may lead to dif-
ferent alterations of pre- and/or postsynaptic inhibition
underlying neuropathic pain and inﬂammatory pain,
respectively.PRESYNAPTIC DISINHIBITION IN
NEUROPATHIC PAIN
Recent years have seen accumulating evidence
suggesting that diminished postsynaptic inhibition plays
a key role in neuropathic pain development and
maintenance. For example, loss of inhibition on PKCY
+
neurons after nerve injury allows low-threshold-
mechanoreceptor signals to gain access to the NS
pathway, an opening of a before-closed gate (Fig. 1)
(Melzack and Wall, 1965; Miraucourt et al., 2007; Kahle
et al., 2008). This may explain the phenomena of tactile
allodynia. The precise basis for the diminished postsynap-
tic inhibition remains to be determined, with reduced
descending inhibitory control, loss of GABAergic interneu-
rons, decreased GABA release, reduced GABA or GABA
synthesizing enzyme (glutamate decarboxylase (GAD)),
altered postsynaptic GABAA receptors and CCC withinthe spinal cord, all having been proposed as possible
mechanisms (Roberts et al., 1986; Castrolopes et al.,
1993; Eaton et al., 1998; Fukuoka et al., 1998; Lever
et al., 2003; Polgar et al., 2003; Munro et al., 2009;
Wang et al., 2013). However, despite the change of post-
synaptic GABAA receptors and CCCs, diminished spinal
GABAergic tone would unavoidably aﬀect presynaptic
inhibition, as well as postsynaptic inhibition. Of particular
interest is the downregulation of GAD65 expression in
the dorsal horn. GAD65 (65 kDa) and GAD67 (67 kDa)
are two isoforms of GAD and are commonly co-expressed
in GABAergic interneurons. At sensory-motor synapses in
the ventral horn, GAD65 has been shown exclusively
associated with terminals presynaptic to primary aﬀerents
whereas GAD67 is associated in addition with GABAergic
terminals that form synapses with dendrites and somata
(Betley et al., 2009). Intriguingly, after nerve injury,
GAD65 mRNA and protein levels declined signiﬁcantly
in all laminae of the ipsilateral dorsal horn while GAD67
levels did not diﬀer (Eaton et al., 1998; Braz et al.,
2012). It would be very interesting to check, whether
GAD65 is also exclusively expressed in the inhibitory bou-
tons that contact sensory terminals in the superﬁcial dor-
sal horn. If yes, the downregulation of GAD65 but not
GAD67 after nerve injury would imply a speciﬁc reduction
of presynaptic inhibition rather than of a postsynaptic
inhibition.
Altered GABAA receptor conductance and EGABA
As noted above, the capacity for neuronal inhibition by
GABAA receptor activation is critically dependent on
[Cl]i. Recent work demonstrates that neuropathic pain
involves the rapid downregulation of KCC2, leading to an
increase of [Cl]i and ultimately produce a reduction of
postsynaptic inhibition thus increases the excitability of
spinal dorsal horn neurons (hyperalgesia) and unmask
non-nociceptive input onto normally NS pathway (tactile
allodynia). However, an increased activity of NKCC1 and
a depolarizing shift of EGABA in DRG neurons have also
been observed after nerve injury in several studies
including our own (Table 2) (Pieraut et al., 2007, 2011;
Wei et al., 2013; Anseloni and Gold, 2008; Chen et al.,
2014; Panek et al., 2002; Modol et al., 2014). Despite
the fact that increased [Cl]i is required for neuronal regen-
eration after peripheral nerve injury (Pieraut et al., 2007),
the shifted EGABA might produce an enhanced PAD which
can increase excitability of primary nociceptors (hyperal-
gesia) or even become suﬃcient enough to directly evoke
an action potential, thus transforming an inhibitory process
into an excitatory one (tactile allodynia) (Cervero et al.,
2003). In vertebrate primary aﬀerent axons, activation of
presynaptic GABAA receptors causes depolarization and
increases membrane conductance (shunting). As we have
discussed above, both PAD and shunting may contribute
to presynaptic inhibition. Thus, besides the alteration of
EGABA in DRG neurons, a regulation of GABAA receptors
following nerve injury may also be an important cause of
neuropathic pain. Indeed, both GABAA receptor a2 and
c2 subunits have been reported to be downregulated
after nerve injury (Fukuoka et al., 1998; Obata et al.,
2003; Lian et al., 2012). Recently, we have performed
Table 2. Summary of the NKCC1 expression in DRG or TG neurons
Type of tissue Pain model Method Expression References
Frog, rat and cat DRG None IHC, western blot All-sized neurons, satellite cells and Schwann
cells in frog, rat and cat
Alvarez-Leefmans
et al. (2001)
Rat DRG & TG None ISH, IHC, western
blot
All-sized DRG and TG neurons; most in small
and medium neurons. mRNA also found in
satellite glia cells
Price et al. (2006)
Rat and mouse DRG None Chloride imaging,
ISH, IHC
All-sized neurons Mao et al. (2012)
Rat DRG None ISH All-sized neurons Kanaka et al. (2001)
Mouse DRG Sciatic nerve section Patch clamp, IHC,
western blot, RT-
PCR
Phosphorylated NKCC1 is responsible for the
increased intracellular chloride concentration
and shifted EGABA-A in axotomized neurons
Pieraut et al. (2007,
2011)
Rat TG CCI ISH, IHC mRNA and protein level were upregulated in
the small-sized and large-sized neurons
Wei et al. (2013)
Mouse DRG CCI Patch clamp, IHC,
western blot
Cell surface NKCC1 level was signiﬁcantly
higher in DRG neurons 2 days after injury and
induced intracellular chloride increase
Chen et al. (2014)
Rat DRG Sciatic nerve
transected and sutured
Western blot, IHC Increased after injury Modol et al. (2014)
Mouse DRG Intracolonic instillation
of capsaicin
Western blot, RT-
PCR
Upregulated in plasma membrane Galan and Cervero
(2005)
Rat DRG Isolated DRG treated
with inﬂammatory
mediators
IHC, RT-PCR Enhanced phosphorylation Funk et al. (2008)
Abbreviations: DRG, dorsal root ganglion; TG, trigeminal ganglion; IHC, immunohistochemistry; ISH, in situ hybridization; RT-PCR, reverse transcription polymerase chain
reaction: CCI, chronic constriction injury.
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from injured mice and observed a decreased GABAA
receptor conductance (GGABA) in parallel with a depolariz-
ing shifted EGABA, both lead to the same alteration of
GABAA receptor function in primary aﬀerents after nerve
injury, i.e. a loss of presynaptic inhibitory eﬀect (Lian
et al., 2012; Chen et al., 2014). Furthermore, we found that
these changes in GGABA and EGABA of DRG neurons are
rather transient and not maintained at later stages, while
persistent neuropathic pain is still present. This observa-
tion is in agreement with a NKCC1 transient upregulation
after nerve injury reported by Modol et al. (2014)). In addi-
tion, Modol et al. also found that blocking NKCC1 by
bumetanide prevented the decrease in KCC2 activity in
the spinal cord, suggesting that the augmented activity
of NKCC1 in DRG is relevant for the downregulation of
pKCC2 in central areas (Ma et al., 1993; Modol et al.,
2014). Factoring all these together, it seems that the tran-
sient modulation of presynaptic inhibition is required for
the initiation of neuropathic pain, but not for the mainte-
nance of pain when increased excitability of projecting
central areas may play a key role.Loss of presynaptic inhibition but no switch to
presynaptic excitation
It has been demonstrated that after nerve injury, the shift
of EGABA in spinal cord neurons could switch postsynaptic
inhibition into excitation (Coull et al., 2003). This raises
the question of whether the depolarizing shift of EGABA
in presynaptic primary sensory neurons would also lead
to an excitatory eﬀect while the conductance of GABAA
receptor is reduced. The ﬁnal consequence of presynaptic
inhibition is to reduce the calcium inﬂux thus thetransmitter release from presynaptic site. In order to
investigate the functional change of presynaptic inhibition
in the spinal cord after nerve injury, we sought to perform
2-photon calcium imaging speciﬁcally in the primary
aﬀerent terminals. To target genetically encoded calcium
sensor to primary aﬀerents, we crossed mice carrying
the ﬂoxed GCaMP3 allele (Ai38) (Zariwala et al., 2012)
to a mouse line expressing Cre recombinase from the
locus of the sensory neuron-speciﬁc gene Advillin (advil-
lin-Cre) (Zurborg et al., 2011). To record the calcium
transients in the primary aﬀerent terminals, we performed
2-photon imaging on the spinal cord slices taken from
control or nerve-injured mice (Garcia-Nicas et al., 2006;
Chen et al., 2014). Interestingly, we found that (1) after
nerve injury the activation of presynaptic GABAA recep-
tors alone does not become excitatory enough to directly
induce Ca2+ inﬂux thus transmitter release from presyn-
aptic sites. (2) A substantial loss of presynaptic inhibition
after nerve injury was observed. The similar phenomenon
has been reported by Wei and colleagues in a trigeminal
neuropathic pain model where they observed a dis-
inhibition and excitation eﬀect on pre- and post-synaptic
GABA actions respectively (Wei et al., 2013). The loss
of presynaptic inhibition rather than switching to presyn-
aptic excitation predicts that after nerve injury, alteration
of presynaptic inhibition will lead to an increased sensitiv-
ity (hyperalgesia) but not an activation of nociceptive
pathway directed by non-nociceptive input (tactile allo-
dynia) (Fig. 1). However, without knowing the relative
contribution of PAD and shunting to presynaptic inhibition
under normal condition, it is diﬃcult to attribute how much
net disinhibition results from shift of EGABA or reduction of
GGABA. A simulation is required to further understand
quantitatively how changes in GABAA receptors and
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tate the design of more targeted therapeutic avenues for
neuropathic pain treatment.Heat hyperalgesia is due to presynaptic disinhibition
Reduced GABAergic inhibitory tone in the spinal cord
after nerve injury has been well documented. Extensive
pharmacological and behavioral evidence show that
neuropathic pain can be relieved by increasing spinal
inhibition. However, all these evidence only demonstrate
that spinal disinhibition is involved in the pathogenesis
of neuropathic pain, but without distinguishing the
relative contribution of pre- and postsynaptic inhibition.
A more speciﬁc study was carried out by investigating
behavioral phenotype of sns- b3/ mice after nerve
injury. As mentioned above, speciﬁcally knocking out of
the GABAA receptor in primary nociceptors led to
spontaneous development of mechanical and heat
hypersensitivity. Interestingly, the heat hypersensitivity
cannot be further sensitized by nerve lesions in sns-
b3/ mice while tactile allodynia developed normally,
which is predicted by presynaptic calcium imaging
results (Chen et al., 2014). Thus, after nerve injury, the
development of tactile allodynia is mostly due to a loss
of postsynaptic inhibition either by an excitatory shift of
GABA eﬀect on spinal cord NS projection neurons or
unmasking the silent input from non-nociceptive ﬁbers in
deep dorsal horn to nociceptive neurons in superﬁcial dor-
sal horn (Bonin and De Koninck, 2013), while the heat
hyperalgesia is generated by a disruption of presynaptic
inhibition (Fig. 1).PRESYNAPTIC DISINHIBITION IN
INFLAMMATORY PAIN
Spinal disinhibition also occurs in response to tissue injury
(Zeilhofer et al., 2012). It has been well established that
peripheral inﬂammation leads to an upregulation of the
pronociceptive and proinﬂammatory prostaglandin E2
(PGE2) in the spinal cord dorsal horn. PGE2, in turn, spe-
ciﬁcally reduces strychnine-sensitive glycinergic inhibition
via a3 subunit containing glycine receptors (GlyRa3)
which are selectively expressed in the superﬁcial dorsal
horn (Ahmadi et al., 2002; Muller et al., 2003; Harvey
et al., 2004; Reinold et al., 2005). Indeed, after subcuta-
neous complete Freund’s adjuvant (CFA) injection, mice
deﬁcient in GlyRa3 recovered from inﬂammatory pain
sensitization much more quickly than corresponding
wild-type mice (Harvey et al., 2004). However, it is worth
mentioning that these mice exhibit normal responses to
acute nociceptive stimuli, and they do develop inﬂamma-
tory pain sensitization as wild-type mice, indicating that
GlyRa3-mediated disinhibition is more required for the
maintenance of inﬂammatory pain but not for the initiation.
Furthermore, recent studies have shown that PGE2-med-
iated inhibition of GlyRa3 appears to be restricted to
inﬂammatory pain since they were not observed to occur
after peripheral nerve injury or acute chemical irritation of
C ﬁbers following capsaicin, formalin, or acetic acid injec-
tion (Hosl et al., 2006; Zeilhofer et al., 2012).Switched presynaptic GABAergic inhibition to
excitation
Similar to after nerve injury, a reduction in KCC2 after
peripheral inﬂammation induced by CFA injection has
also been reported which can eﬀectively eliminate
inhibition mediated by GABA and glycine (Zhang et al.,
2008). As mentioned above, loss of GABAA receptor-
mediated spinal inhibition after injury has been regarded
as a key feature that contributes to signs and symptoms
of pathological pain for decades. However, the eﬀect of
facilitating spinal GABAergic pathway diﬀers between
neuropathic pain and inﬂammatory pain. After nerve
injury, most behavioral experiments with systemic or cen-
trally administering GABAA agonists show analgesic
eﬀects (Yamamoto and Yaksh, 1993; Hwang and
Yaksh, 1997; Eaton et al., 1999; Kontinen and
Dickenson, 2000; Stubley et al., 2001; Malan et al.,
2002; Miletic et al., 2003; Sokal and Chapman, 2003;
Rode et al., 2005; Gwak et al., 2006; Mukhida et al.,
2007; Knabl et al., 2008; Naik et al., 2008; Asiedu et al.,
2010). In contrast, paradoxically, both GABAA agonists
and GABAA receptor antagonists have been reported to
mediate behavioral analgesia after tissue injury (Dirig
and Yaksh, 1995; Kaneko and Hammond, 1997; Weng
et al., 1998; Carlton et al., 1999; Anseloni and Gold,
2008; Knabl et al., 2008; Boegel et al., 2011; Munro
et al., 2011). It has been suggested that this paradox
eﬀect is due to an imbalance of spinal GABA function after
tissue damage, i.e. reduced postsynaptic GABAergic inhi-
bition vs. switched presynaptic GABAergic inhibition to
excitation. Compared to nerve injury, inﬂammation may
induce a much more intense form of PAD suﬃcient to trig-
ger action potential and to elicit so-called dorsal root
reﬂexes (DRR), thereby rendering the normal inhibitory
eﬀect of PAD into an excitation (Willis, 1999). Inputs from
non-nociceptive ﬁbers could then, via interconnected
GABAergic interneurons, evoke action potentials in noci-
ceptive aﬀerents, from where excitation could spread both
anterogradely and retrogradely, to induce touch-evoked
pain and neurogenic inﬂammation (Fig. 1) (Cervero
et al., 2003; Price et al., 2005, 2009; Garcia-Nicas
et al., 2006). In this way, GABAA receptor antagonist or
compounds capable of negatively modulating GABAA
receptor function might possess analgesic activity (Mirza
and Munro, 2010; Munro et al., 2011).
Indeed, electrophysiological studies from Willis and
Westlund’s laboratory described an enhancement of
DRRs induced by an experimental inﬂammation of the
joints (Rees et al., 1994, 1995, 1996; Sluka et al.,
1995). A number of reports have shown that DRR activity
not only can be antidromically detected (Sluka et al.,
1995; Rees et al., 1996; Lin et al., 2000) contributing to
the development of neurogenic inﬂammation (Rees
et al., 1994; Lin et al., 1999; Garcia-Nicas et al., 2001),
but can also propagate orthodromically causing excitation
of second-order neurons in the spinal cord (Cervero and
Laird, 1996). Multiple lines of evidence indicate that
PAD is enhanced, through increased NKCC1 activity, in
hyperalgesic states leading to the generation of DRRs
(Rees et al., 1994, 1995; Lin et al., 2000). Indeed, these
DRRs can be blocked by spinal application of GABAA
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conﬁrming that NKCC1-regulated presynaptic GABA acti-
vation contributes to DRR generation (Valencia-de Ita
et al., 2006). In line with this, NKCC1 activity has been
shown to be upregulated after tissue injury or inﬂamma-
tory mediator treatment (Table 2) (Galan and Cervero,
2005; Nomura et al., 2006; Funk et al., 2008; Scamps
et al., 2008; Kahle et al., 2008; Delpire and Austin,
2010; Schobel et al., 2012). In addition, NKCC1 knockout
mice do not display touch-evoked pain after intradermal
capsaicin application (Laird et al., 2004). Consistent with
the increased activity of NKCC1, a depolarizing shifted
EGABA in DRG neurons after inﬂammation has also been
recorded (Vaughn and Gold, 2010; Zhu et al., 2012).
However, as observed under neuropathic pain
condition, a depolarizing shift of EGABA alone may lead
to a less inhibitory eﬀect of presynaptic inhibition but
may not necessarily produce suprathreshold GABAergic
depolarization in sensory terminals, yielding cross
excitation between low- and high-threshold aﬀerents
(Chen et al., 2014). An increase in GABA-mediated depo-
larization also depends on the conductance of presynap-
tic GABAA receptor. A decreased GGABA combined with a
shifted EGABA after nerve injury leads to a loss of presyn-
aptic inhibition but is not suﬃcient to produce action
potentials in nociceptive ﬁbers thus an opening of the
nociceptive gate by a non-nociceptive stimulus. Interest-
ingly, in contrast to nerve injury, inﬂammatory mediators
have been shown to potentiate high-aﬃnity GABAA
currents in DRG neurons (Lee and Gold, 2012). In the
CFA model of inﬂammatory pain, the GABA-induced
depolarization in DRG neurons has been reported to be
signiﬁcantly enhanced accompanied by an increase in
the number of neurons which respond to GABA with a
Ca2+ transient (Zhu et al., 2012), indicating that GABA
becomes a presynaptic excitatory neurotransmitter in
some inﬂammatory pain states.Tactile allodynia is due to presynaptic disinhibition
Recent work has revealed a good correlation between
NKCC1 activity and inﬂammatory pain (Granados-Soto
et al., 2005; Valencia-de Ita et al., 2006; Pitcher and
Cervero, 2010; He et al., 2011; Pitcher et al., 2013), but it
remains unproven whether presynaptic GABAA receptors
are speciﬁcally required to produce the nociceptive path-
way activation by non-nociceptive input that may in turn
cause the behavioral features of inﬂammatory pain, such
as tactile allodynia. In order to test this, we have compared
the behavioral phenotype of sns- b3/mice and their wild-
type littermates after CFA injection. Remarkably, sns- b3/
 mice did not develop any tactile allodynia while the heat
hyperalgesia progressed similar in knockout and wild-type
mice (unpublished observation). Compared to wild-type
mice, sns- b3/ mice show signiﬁcantly less edema.
These observations are consistent with the hypothesis that
presynaptic GABAA receptor on nociceptive aﬀerent
terminals is the key element of tissue injury-induced
inﬂammation and tactile allodynia (Cervero et al., 2003).
An alternative explanation of this phenotype in sns-
b3/ mice is an imbalance between inhibitory andexcitatory inputs to the nociceptive pathway which
ultimately unmasks the otherwise silent excitatory input
from non-nociceptive neurons. The fact the strong tactile
allodynia can be induced within minutes by disinhibition
of spinal networks through acute blockade of spinal
GABAergic or glycinergic transmission suggests that
there exists a hard-wired pathway which is normally
under strong inhibitory control (Fig. 1) (Kuner, 2010).
Electrophysiological studies show that whereas only
high-threshold monosynaptic inputs are found on NS pro-
jection neurons under normal circumstances, blockade of
local inhibition uncovers substantial Ab, low-threshold
ﬁber inputs, which are polysynaptic (Baba et al., 2003).
The strong inhibition may come from glycinergic input
onto PKCY
+ neurons in the superﬁcial dorsal horn, but it
may also comprise the input from GABAergic interneu-
rons onto excitatory interneurons as shown in Fig. 1.
Any disruption of these inhibitory controls can result in
nociceptive circuits being engaged by innocuous stimuli.
There is evidence that the GABAergic islet cells receive
input from nociceptive C ﬁbers (Nakatsuka et al., 2005;
Yasaka et al., 2007; Zheng et al., 2010) which are under
presynaptic inhibitory control of Ab ﬁbers. Further on,
these islet cells can inhibit other inhibitory interneurons
(Kato et al., 2007; Labrakakis et al., 2009; Zheng et al.,
2010), thus a disinhibitory circuit functions as a gate in
controlling the ultimate transmission of the touch informa-
tion to the NS projection neurons (Yasaka et al., 2007;
Labrakakis et al., 2009; Braz et al., 2014). After injury,
the presynaptic inhibition is diminished thus the input to
this disinhibitory circuit is increased which will in turn
reduce the inhibitory control onto excitatory interneuron,
open the gate between Ab ﬁber and NS projection neu-
rons, and produce touch-induced pain. This is diﬀerent
from nerve injury-induced tactile allodynia which is due
to the decreased glycinergic inhibition onto PKCY
+ neu-
rons, indicating diﬀerent groups of neurons thus diﬀerent
circuits are involved in neuropathic and inﬂammatory
pain. For example, Abrahamsen and colleagues demon-
strated that diﬀerent types of primary aﬀerent sensory
ﬁbers mediate inﬂammatory and neuropathic hyperalge-
sia (Abrahamsen et al., 2008). In addition, study of a
mouse model which lacks many excitatory interneurons
in the superﬁcial dorsal horn displays normal inﬂamma-
tory pain but not neuropathic pain strongly suggests that
diﬀerent subsets of neuronal circuits contribute to tissue
and nerve injury-induced heat and mechanical pain
(Wang et al., 2013).
Simulations of postsynaptic inhibition reveal that, after
nerve injury, even a small depolarizing shift of EGABA
compromises GABAergic inhibitory control of ﬁring rate
in spinal cord neurons, because shift of EGABA not only
decreases GABAA-mediated hyperpolarization, but also
indirectly compromises the capacity of shunting to
reduce spiking. The latter eﬀect occurs because
shunting-mediated inhibition depends on a competition
between two opposing biophysical phenomena: shunting
reduces depolarization, thereby decreasing ﬁring rate
vs. shunting shortens the membrane time constant,
thereby fastening membrane charging and increasing
spiking. The second eﬀect predominates when average
D. Guo, J. Hu /Neuroscience 283 (2014) 95–106 103depolarization is suprathreshold, causing GABAA-
mediated inputs to become paradoxically excitatory
(Prescott et al., 2006). Given this new understanding of
the biophysical mechanisms, one would predict that the
decreased GGABA which indicates a reduced shunting
eﬀect observed after nerve injury may determine a reduc-
tion of inhibition, thus leading to enhanced ﬁring to nox-
ious stimulus (hyperalgesia). On the contrary, an
increased GGABA after inﬂammatory injury would switch
presynaptic inhibition to excitation, hence a cross activa-
tion of nociceptive pathway by nonnociceptive input
(tactile allodynia). These theoretical predictions are
consistent with our observation in sns- b3/ mice that
presynaptic GABAA receptor activation contributes to
thermal hyperalgesia after nerve injury but to tactile allo-
dynia after tissue injury. However, as well established
for presynaptic inhibition, EGABA is already depolarized
in primary aﬀerents and the GABAA receptors are presyn-
aptically located, it is very diﬃcult to make a simple pre-
diction based on the simulations of postsynaptic
inhibition. A quantitative and biophysically accurate model
speciﬁc for presynaptic inhibition is required to decipher
this complex interplay between the changes of EGABA
and GGABA, and understand how these changes lead to
a reduction of inhibition, an enhancement of orthodromic
propagation of action potentials from periphery or being
suﬃcient to directly induce action potentials after nerve
or tissue injury.CONCLUSION
Here we provide a comprehensive review of diﬀerent
contributions of presynaptic inhibition to neuropathic and
inﬂammatory pain by integrating recent advances in
both chronic pain models. Although the behavioral
symptoms of neuropathic pain and inﬂammatory pain
are similar, the underlying mechanisms are not
necessarily the same. As we have discussed above,
after nerve injury and tissue injury, the spinal
presynaptic inhibition undergoes diﬀerent changes,
which result in enhanced behavioral responses to
noxious and innocuous stimuli. After nerve injury, a
reduction of glycinergic postsynaptic inhibition onto
PKCY
+ neurons, accompanied by an increased [Cl]i in
spinal cord neurons which leads to less eﬃcacy of both
GABA- and glycine-mediated inhibition would ultimately
unmask the input from non-nociceptive ﬁbers to NS
projection neurons and produce tactile allodynia. In
parallel, there is a depolarizing shift of EGABA and a
reduced GGABA in primary sensory aﬀerents, which
contributes speciﬁcally to the development of heat
hyperalgesia but not tactile allodynia. In contrast, after
tissue injury, a depolarizing shift of EGABA in conjunction
with increased GGABA in primary nociceptors will render
presynaptic inhibition into excitation and generate DRR
thus contributing to tactile allodynia and neurogenic
inﬂammation. We have also emphasized the importance
and urgent need of a mathematic modeling study to
understand the relative contribution of changes in
intracellular chloride concentration and GABAA receptor
expression to chronic pain development. However, itremains to be seen whether the presynaptic inhibition
alteration is only a mechanism for a short-term induction
of heat hyperalgesia and tactile allodynia or if a similar
process could also operate for maintaining the longer
lasting phases of chronic pain.
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